Mulmit

Biofrontera Inc.Biofrontera Inc.

BFRI Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3141,705,000-11,348,000-10,536,000-1.04
2024-12-3137,321,000-17,210,000-17,759,000-3.22
2023-12-3134,071,000-22,677,000-20,131,000-13.02
2022-12-3128,674,000-18,581,000-640,000-0.61
2021-12-3124,043,000-25,201,000-37,713,000—

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-07-28Luebbert HermannCEO & Chairman62,500
2026-07-28Luebbert HermannCEO & Chairman62,500
2026-07-28Leffler Eugene FrederickChief Financial Officer31,250
2026-07-28Leffler Eugene FrederickChief Financial Officer31,250
2026-03-05Luebbert HermannCEO & Chairman137,500
2026-03-05Luebbert HermannCEO & Chairman137,500
2026-03-05Leffler Eugene FrederickChief Financial Officer87,500
2026-03-05Leffler Eugene FrederickChief Financial Officer87,500
2026-03-04Weber Kevin Daniel20,000
2026-03-04Luebbert HermannCEO & Chairman125,000
2026-03-04Luebbert HermannCEO & Chairman125,000
2026-03-04Leffler Eugene FrederickChief Financial Officer62,500

8-K events

FiledItems
2026-09-14Other events · Financial statements and exhibits
2026-08-13Results of operations · Financial statements and exhibits
2026-06-17Submission of matters to a vote
2026-05-14Results of operations · Financial statements and exhibits
2026-03-19Results of operations · Financial statements and exhibits
2026-03-09Regulation FD disclosure · Financial statements and exhibits
2026-02-26Other events · Financial statements and exhibits
2026-02-09Regulation FD disclosure · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.

한국 시장 대시보드Korea dashboard 미국·글로벌 대시보드US & Global dashboard